27 DAFTAR KEPUSTAKAAN
1. Bahl V, Mei Hu H, Henke P, Wakefield T, Campbell D, Caprini J, A validation study of a retrospective venous thromboembolism risk scoring method, Ann Surg. 2010;251: 344-50
2. Cushman M. Epidemiology and risk factors for venous thrombosis. Semin
Hematol. 2007; 44(2): 62-9
3. Caprini J. Risk factors for venous thromboembolism. Excepta Medica, Inc., an Elsevier business. All rights reserved. Release date: May 2005.
4. Ahmed M, Elshrif H, Masoud A, Altaher A. Deep Vein Thrombosis. Sebha Medical Journal, 2013; 12(2):6-11.
5. Cohen A. Asia-Pacific thrombosis advisory board consensus paper on prevention of venous thromboembolism after major orthopaedic surgery.
Thromb Haemost 2010; 104: 919-930
6. Hirsh J, Hull R, Raskob G. Epidemiology and pathogenesis of venous thrombosis. J Am Coli Cardiol.1986;8:104-13B
7. Hudgens S, Cella D, Caprini C, Caprini J. Deep vein thrombosis: validation of a patient-reported leg symptom index. Health and Quality of Life Outcomes 2003, 1:76
8. Hotoleanu C, Fodor D, Suciu O. Correlations between clinical probability and Doppler ultrasound results in the assessment of deep venous thrombosis. Medical ultrasonography. 2010; 12(1):17-21.
9. Shbaklo H, Kahn S, Long-term prognosis after deep venous thrombosis. Hematology. 2008;15:494-8
10. Kesieme E, Kesieme C, Jebbin N, Irekpita E, Dongo A. Deep vein thrombosis: a clinical review. Journal of Blood Medicine. 2011;2:59-69
11. Kroegel C, Reissig A. Principle mechanisms underlying venous thromboembolism: epidemiology risk factors, pathophysiology and pathogenesis. Respiration. 2003;70:7-30
28 12. Brooks E, Trotman W, Wadsworth M, Taatjer D, Evans M, Ittleman F,et al.
Valves of the deep venous system: an overlooked risk factor. Blood. 2009;114:1276-9
13. Malone P, Agutter P. The aetiology of deep venous thrombosis. QJ Med 2006; 99:581-93
14. Esmon C. Basic mechanism and pathogenesis of venous thrombosis. Blood. 2009;23(5):225-229
15. The American Thoracic Society. The diagnostic approach to acute venous thromboembolism. Am J Respir Crit Care Med. 1999;160:1043-66
16. Kahn S. The clinical diagnosis of deep venous thrombosis. Arch Intern Med. 1998;158: 2315-23
17. Caprini J, Glase C, Anderson C, Hathaway K. Laboratory markers in the diagnosis of venous thromboembolism. Circulation. 2004;10:1-8
18. Riddle D, Wells P. Diagnosis of Lower-Extremity deep vein thrombosis in outpatients. Physther. 2004;84:729-35
19. Kelly J, Rudd A, Lewis R, Hunt B. Screening for subclinical deep-vein thrombosis. Q J Med. 2001;94:511-19
20. Zierler B. Ultrasonography and diagnosis of venous thromboembolism, Circulation. 2004;109: 9-14
21. Pannucci C, Bailey S, Dreszer G, Fisher C, Zumsteg J. Validation of the Caprini risk assessment model in plastic and reconstructive surgery Patients, J Am Coll Surg. 2011;212(1):105-12
22. Pop T, Vesa S, Trifa A, Crisan S, Buzoianv A. PAI-1 4G/5G and MTHFR C677T polymorphisms increased the accuracy of two prediction scores for the risk of acute lower extremity deep vein thrombosis. Rom J Morphol Embryol. 2014;55(1)153-7.
23. Caprini J. Thrombosis risk assessment as a guide to quality patient care. Dis
Mon 2005; 51: 70-78
24. Wessels P, Riback W. DVT prophylaxis in relation to patient risk profiling –the tune in study. S Afr Med J. 2012;102:85-9
29 25. Mozafar M, Shahabodin M, Lotfollahzadeh S, Motamedi M, Sobhiyeh M.
Application of Wells criteria in combination with serum d-dimer to rule out deep vein thrombosis in lower extremities. Scimetr. 2014;2(1):1-6
26. Rahiminejad M, Rastogi A, Prabhudesai S, Mcclinton D, MacCallum P, Platon S, et al. Evaluating the use of a negative d-dimer and modified low Wells score in excluding above knee deep venous thrombosis in and outpatient population, assessing need for diagnostic ultrasound. ISRN
Radiology. 2014;1-5.
27. Goodacre S, Sampson F, Thomas S, Beek E, Sutton A. Systematic review and meta-analysis of the diagnostic accuracy of ultrasonography for deep vein thrombosis. BMC Medical Imaging 2005, 5:6
28. Leavit M. The surgeon general’s call to action to prevent deep vein thrombosis and pulmonary embolism. U.S Departement of Health and Human Services. 2008;1-41.
29. Nendaz M, Spirk D, Kucher, Aujesky D, Hayoz D, et al, Multicentre
validation of the Geneva Risk Score for hospitalized, medical patients at
risk of venous thromboembolism Explicit ASsessment of Thromboembolic
RIsk and Prophylaxis for Medical PATients in SwitzErland (ESTIMATE),
Thromb Haemost 2014; 111
30. Cihan A, Dunkler D, Marosi C, Chiriac AL, Vormittag R,et al, Prediction of venous thromboembolism in cancer patients, BLOOD, 2010 v 116, p 5377-82
31. Carrier M, Lee A, Bates S, Wells PS, Accuracy and Usefullnes of a Clinical Prediction Rule and D Dimer Testing in Excluding DVT in Cancer Patients, Journal of Clinical Oncology Vol 25, 2007
32. RADU P T, VESA SC, TRIFA AP CRIŞAn S, BUZOIANU AD, PAI-1 4G/5G and MTHFR C677T polymorphisms increased the accuracy of two
prediction scores for the risk of acute lower extremity deep vein thrombosis, Rom J Morphol Embryol 2014, 55(1):153–157
33. Alfahad A, Jan A, Curtin J, Norwich, The correlation between Wells pre-test probability scoring and DVT result in our practice, Europian Society of Radiology, 2013
